JPRN-UMIN000009074
Completed
未知
A study of expression levels of the interferon regulated genes in Japanese systemic lupus erythematosus patients with moderate to severe disease activities and healthy adults - A study of expression levels of the interferon regulated genes in Japanese systemic lupus erythematosus patients
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Chugai Pharmaceutical co., ltd.
- Enrollment
- 110
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(ERL/LN) \-Unstable neuropsychiatric SLE at the time of sampling. \-Evidence of significant uncontrolled concomitant diseases (e.g., cardiovascular, nervous system, pulmonary, renal, hepatic, endocrine, or gastrointestinal disorders) at the time of sampling. \-Conditions other than SLE that could require treatment with corticosteroids (e.g., asthma) at the time of within 12 months prior to sampling. \-History of cancer within 5 years prior to sampling. \-History of congenital immunodeficiency. \-Signs or symptoms of infection within 31 days prior to sampling (Healthy adults) \-Evidence of concomitant diseases (e.g., cardiovascular, nervous system, pulmonary, renal, hepatic, endocrine, or gastrointestinal disorders) at the time of sampling. \-History of cancer within 5 years prior to sampling. \-Any clinically abnormal conditions at the time of sampling. \-Signs or symptoms of infection within 31 days prior to sampling.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A study of expression levels of the interferon regulated genes in Japanese systemic lupus erythematosus patients with moderate to severe disease activities and healthy adultsSystemic lupus erythematosusJPRN-UMIN000008987Chugai Pharmaceutical co., ltd.110
Completed
Not Applicable
A study of expression levels of the interferon regulated genes in Japanese systemic lupus erythematosus patients with moderate to severe disease activities and healthy adultsSystemic lupus erythematosusJPRN-UMIN000009040Chugai Pharmaceutical co., ltd.110
Completed
Not Applicable
A study of expression levels of the interferon regulated genes in Japanese systemic lupus erythematosus patients with moderate to severe disease activities and healthy adultsJPRN-UMIN000008787Chugai Pharmaceutical co., ltd.110
Not yet recruiting
Not Applicable
Correlation of antiviral molecules with viruses in gum diseasesHealth Condition 1: R893- Abnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissuesCTRI/2019/01/016854Dr Shivaprasad BM
Completed
Not Applicable
The role of antiviral agents in gum health and diseaseHealth Condition 1: null- Chronic and aggressive periodontitis patientsCTRI/2017/10/010244Dr Shivaprasad BM90